130 related articles for article (PubMed ID: 29674761)
21. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma.
Fleming JB; Gonzalez RJ; Petzel MQ; Lin E; Morris JS; Gomez H; Lee JE; Crane CH; Pisters PW; Evans DB
Arch Surg; 2009 Mar; 144(3):216-21. PubMed ID: 19289659
[TBL] [Abstract][Full Text] [Related]
22. Impact of being underweight on the long-term outcomes of patients with gastric cancer.
Migita K; Takayama T; Matsumoto S; Wakatsuki K; Tanaka T; Ito M; Kunishige T; Nakade H; Nakajima Y
Gastric Cancer; 2016 Jul; 19(3):735-43. PubMed ID: 26298184
[TBL] [Abstract][Full Text] [Related]
23. Lower body mass index predicts worse cancer-specific prognosis in octogenarians with colorectal cancer.
Adachi T; Hinoi T; Kinugawa Y; Enomoto T; Maruyama S; Hirose H; Naito M; Tanaka K; Miyake Y; Watanabe M
J Gastroenterol; 2016 Aug; 51(8):779-87. PubMed ID: 26660524
[TBL] [Abstract][Full Text] [Related]
24. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
[TBL] [Abstract][Full Text] [Related]
25. Impact of Body Mass Index of Japanese Gallbladder Cancer Patients on their Postoperative Outcomes.
Fujii M; Fujimoto K; Yabe S; Nasu J; Miyaike J; Yoshioka M; Shiode J; Yamamoto K; Matsuda S
Acta Med Okayama; 2019 Feb; 73(1):51-59. PubMed ID: 30820054
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
Surgery; 2016 Feb; 159(2):426-40. PubMed ID: 26253244
[TBL] [Abstract][Full Text] [Related]
27. Postoperative Neutrophil-to-Lymphocyte Ratio as a Predictor of Long-Term Prognosis after Pancreatectomy for Pancreatic Carcinoma: A Retrospective Analysis.
Tsujita E; Ikeda Y; Kinjo N; Yamashita YI; Hisano T; Furukawa M; Taguchi KI; Morita M; Toh Y; Okamura T
Am Surg; 2017 Jun; 83(6):610-616. PubMed ID: 28637563
[TBL] [Abstract][Full Text] [Related]
28. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy.
Roland CL; Katz MH; Tzeng CW; Lin H; Varadhachary GR; Shroff R; Javle M; Fogelman D; Wolff RA; Vauthey JN; Crane CH; Lee JE; Fleming JB
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1221-8. PubMed ID: 26350371
[TBL] [Abstract][Full Text] [Related]
29. Body mass index and pancreatic adenocarcinoma: A nationwide registry-based cohort study.
Saeed U; Myklebust TÅ; Robsahm TE; Møller B; Mala T; Skålhegg BS; Yaqub S
Scand J Surg; 2023 Mar; 112(1):11-21. PubMed ID: 36173093
[TBL] [Abstract][Full Text] [Related]
30. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
31. Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer.
Min EK; Chong JU; Hwang HK; Pae SJ; Kang CM; Lee WJ
World J Gastroenterol; 2017 Jan; 23(4):676-686. PubMed ID: 28216975
[TBL] [Abstract][Full Text] [Related]
32. Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer.
Epstein AS; Soff GA; Capanu M; Crosbie C; Shah MA; Kelsen DP; Denton B; Gardos S; O'Reilly EM
Cancer; 2012 Jun; 118(12):3053-61. PubMed ID: 21989534
[TBL] [Abstract][Full Text] [Related]
33. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
34. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
[TBL] [Abstract][Full Text] [Related]
36. Impact of Body Mass Index on Complications and Survival after Surgery for Esophageal and Gastro-Esophageal-Junction Cancer.
Kruhlikava I; Kirkegård J; Mortensen FV; Kjær DW
Scand J Surg; 2017 Dec; 106(4):305-310. PubMed ID: 28737095
[TBL] [Abstract][Full Text] [Related]
37. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors.
Skírnisdóttir I; Sorbe B
Acta Obstet Gynecol Scand; 2010; 89(1):101-7. PubMed ID: 19878086
[TBL] [Abstract][Full Text] [Related]
38. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
40. Malnutrition and pancreatic surgery: prevalence and outcomes.
La Torre M; Ziparo V; Nigri G; Cavallini M; Balducci G; Ramacciato G
J Surg Oncol; 2013 Jun; 107(7):702-8. PubMed ID: 23280557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
